Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma

Medicine and Dentistry

• B Cell 100%
• Diffuse Large B-Cell Lymphoma 100%
• Multiple Myeloma 100%
• Cancer Cell Line 100%
• Drug Effect 100%
• Gene 60%
• Drug Resistance 40%
• Clinical Trial 40%
• Diseases 20%
• Drug Therapy 20%
• Phenotype 20%
• Gene Expression 20%
• Cancer Cell 20%
• Cell Lineage 20%
• Drug Screening 20%
• Programmed Cell Death 20%
• Doxorubicin 20%
• Angiogenesis 20%
• Rituximab 20%
• Cyclophosphamide 20%
• Metastatic Carcinoma 20%
• Melphalan 20%
• Vincristine 20%
• Gene Function 20%
• Alkylating Antineoplastic Agent 20%
• Gyrase Inhibitor 20%
• Mitotic Inhibitor 20%
• Drug Resistance in Cancer 20%
• CD20 Antibody 20%
• Chemotherapeutic Agent 20%
• Malignant Neoplasm 20%
• Drug 20%
• Analysis 20%
• Laboratory 20%
• Human 20%
• Tenidap 20%
• Cells 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Multiple Myeloma 100%
• Diffuse Large B Cell Lymphoma 100%
• Malignant Neoplasm 100%
• Drug 100%
• Drug Resistance 60%
• DNA 20%
• Diseases 20%
• Rituximab 20%
• Doxorubicin 20%
• Cyclophosphamide 20%
• Melphalan 20%
• Metastasis 20%
• Vincristine 20%
• Human 20%
• CD20 Antibody 20%
• Tenidap 20%
• Pharmaceutical Therapy 20%
• Cell Death 20%
• Alkylating Agent 20%
• Drug Screening 20%